Published in J Exp Med on October 01, 1973
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med (2006) 1.93
Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer (2010) 1.92
Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med (1975) 1.74
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A (2009) 1.67
Paper-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A (2009) 1.60
In vitro perfused human capillary networks. Tissue Eng Part C Methods (2013) 1.57
Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47
Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer (1977) 1.39
Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg (1998) 1.29
Fibrin gel-immobilized VEGF and bFGF efficiently stimulate angiogenesis in the AV loop model. Mol Med (2007) 1.27
Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia (2014) 1.23
Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proc Natl Acad Sci U S A (2012) 1.23
Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials (2009) 1.20
The role of the vascular phase in solid tumor growth: a historical review. Neoplasia (1999) 1.20
Nonsteady state oxygen transport in engineered tissue: implications for design. Tissue Eng Part A (2013) 1.07
Osteoinduction and survival of osteoblasts and bone-marrow stromal cells in 3D biphasic calcium phosphate scaffolds under static and dynamic culture conditions. J Cell Mol Med (2012) 1.05
Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci U S A (1980) 1.04
Evaluation of processed bovine cancellous bone matrix seeded with syngenic osteoblasts in a critical size calvarial defect rat model. J Cell Mol Med (2006) 1.04
Development of an innovative 3D cell culture system to study tumour--stroma interactions in non-small cell lung cancer cells. PLoS One (2014) 1.03
Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia. J Cell Mol Med (2011) 1.03
Front instabilities and invasiveness of simulated avascular tumors. Bull Math Biol (2009) 1.02
Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis (2008) 1.00
Will regenerative medicine replace transplantation? Cold Spring Harb Perspect Med (2013) 1.00
Cellular potts modeling of tumor growth, tumor invasion, and tumor evolution. Front Oncol (2013) 0.99
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. Front Oncol (2013) 0.99
Gene therapy for brain tumors: basic developments and clinical implementation. Neurosci Lett (2012) 0.98
A review of cellularization strategies for tissue engineering of whole organs. Front Bioeng Biotechnol (2015) 0.97
Preneoplastic lesion growth driven by the death of adjacent normal stem cells. Proc Natl Acad Sci U S A (2008) 0.97
Proliferation of myoblast skeletal cells on three-dimensional supermacroporous cryogels. Int J Biol Sci (2010) 0.97
Evaluation of blood vessel ingrowth in fibrin gel subject to type and concentration of growth factors. J Cell Mol Med (2008) 0.96
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology. ALTEX (2014) 0.94
Diffusion and perfusion: the keys to fat grafting. Plast Reconstr Surg Glob Open (2014) 0.92
Properties of tumor spheroid growth exhibited by simple mathematical models. Front Oncol (2013) 0.91
Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat. J Cell Mol Med (2008) 0.91
Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion. Biomed Eng Online (2010) 0.90
Judah Folkman, a pioneer in the study of angiogenesis. Angiogenesis (2008) 0.90
A biodegradable microvessel scaffold as a framework to enable vascular support of engineered tissues. Biomaterials (2013) 0.89
A microdevice for the creation of patent, three-dimensional endothelial cell-based microcirculatory networks. Biomicrofluidics (2011) 0.89
Vascularization in bone tissue engineering constructs. Ann Biomed Eng (2015) 0.89
Bioprocess forces and their impact on cell behavior: implications for bone regeneration therapy. J Tissue Eng (2011) 0.89
The role of stress in the growth of a multicell spheroid. J Math Biol (2003) 0.89
A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiat Oncol (2015) 0.88
Differences in predictions of ODE models of tumor growth: a cautionary example. BMC Cancer (2016) 0.88
A perspective on the clinical translation of scaffolds for tissue engineering. Ann Biomed Eng (2014) 0.88
Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments. J Cell Mol Med (2010) 0.87
Endothelialized biomaterials for tissue engineering applications in vivo. Trends Biotechnol (2011) 0.85
Designer blood vessels and therapeutic revascularization. Br J Pharmacol (2003) 0.84
Endothelial cells enhance the in vivo bone-forming ability of osteogenic cell sheets. Lab Invest (2014) 0.84
A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice. J Cancer Res Clin Oncol (2012) 0.84
Oxygen Releasing Biomaterials for Tissue Engineering. Polym Int (2013) 0.83
Cell interactions in bone tissue engineering. J Cell Mol Med (2009) 0.83
Induction of osteogenic differentiation of adipose derived stem cells by microstructured nitinol actuator-mediated mechanical stress. PLoS One (2012) 0.81
Adenovirus-mediated transfer of VEGF into marrow stromal cells combined with PLGA/TCP scaffold increases vascularization and promotes bone repair in vivo. Arch Med Sci (2012) 0.81
Predicting in vivo glioma growth with the reaction diffusion equation constrained by quantitative magnetic resonance imaging data. Phys Biol (2015) 0.81
Strategies for improving the efficacy of bioengineered bone constructs: a perspective. Osteoporos Int (2011) 0.80
Vascularization of three-dimensional collagen hydrogels using ultrasound standing wave fields. Ultrasound Med Biol (2011) 0.80
Vascular guidance: microstructural scaffold patterning for inductive neovascularization. Stem Cells Int (2010) 0.80
Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80
Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environments. Tissue Eng Part A (2012) 0.79
On the genealogy of tissue engineering and regenerative medicine. Tissue Eng Part B Rev (2014) 0.79
A 3-D model of tumor progression based on complex automata driven by particle dynamics. J Mol Model (2009) 0.79
Three-dimensional 10% cyclic strain reduces bovine aortic endothelial cell angiogenic sprout length and augments tubulogenesis in tubular fibrin hydrogels. J Tissue Eng Regen Med (2010) 0.79
Bioengineering kidneys for transplantation. Semin Nephrol (2014) 0.79
Longitudinal, quantitative monitoring of therapeutic response in 3D in vitro tumor models with OCT for high-content therapeutic screening. Methods (2013) 0.79
In silico experimental modeling of cancer treatment. ISRN Oncol (2012) 0.79
Upcyte® microvascular endothelial cells repopulate decellularized scaffold. Tissue Eng Part C Methods (2012) 0.78
Molecular targets and targeted therapies in bladder cancer management. World J Urol (2008) 0.78
Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites. Br J Cancer (1984) 0.78
Tissue engineering strategies for promoting vascularized bone regeneration. Bone (2015) 0.78
Cell-based therapy for urinary incontinence. Korean J Urol (2010) 0.78
Angiogenesis, cell differentiation and cell survival in tissue engineering and cancer research. GMS Interdiscip Plast Reconstr Surg DGPW (2015) 0.78
Front instabilities and invasiveness of simulated 3D avascular tumors. PLoS One (2010) 0.77
A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics. Bull Math Biol (2014) 0.77
Using Fractal Geometry and Universal Growth Curves as Diagnostics for Comparing Tumor Vasculature and Metabolic Rate With Healthy Tissue and for Predicting Responses to Drug Therapies. Discrete Continuous Dyn Syst Ser B (2013) 0.77
Efficient coarse simulation of a growing avascular tumor. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 0.77
Changing T-cell enigma: cancer killing or cancer control? Cell Cycle (2013) 0.76
Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time. Br J Radiol (2013) 0.76
Embryological Origin of Human Smooth Muscle Cells Influences Their Ability to Support Endothelial Network Formation. Stem Cells Transl Med (2016) 0.76
In silico modeling for tumor growth visualization. BMC Syst Biol (2016) 0.76
Elastic free energy drives the shape of prevascular solid tumors. PLoS One (2014) 0.76
An Interactive Tool for Animating Biology, and Its Use in Spatial and Temporal Modeling of a Cancerous Tumor and Its Microenvironment. PLoS One (2015) 0.76
Manipulating the microvasculature and its microenvironment. Crit Rev Biomed Eng (2013) 0.76
Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery. Sci Rep (2016) 0.75
Cellularized biosynthetic microhydrogel polymers for intravascular liver tissue regeneration therapy. Tissue Eng Part A (2014) 0.75
Applications of Alginate-Based Bioinks in 3D Bioprinting. Int J Mol Sci (2016) 0.75
The tumor as an organ: comprehensive spatial and temporal modeling of the tumor and its microenvironment. BMC Bioinformatics (2016) 0.75
Supportive angiogenic and osteogenic differentiation of mesenchymal stromal cells and endothelial cells in monolayer and co-cultures. Int J Oral Sci (2016) 0.75
Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions. PLoS One (2016) 0.75
Quest for the Vulnerable Atheroma: Carotid Stenosis and Diametric Strain-A Feasibility Study. Ultrasound Med Biol (2015) 0.75
Internal pressure and oxygen tension of bone tumors and tumorous conditions. Arch Orthop Trauma Surg (1986) 0.75
A Model for Spheroid versus Monolayer Response of SK-N-SH Neuroblastoma Cells to Treatment with 15-Deoxy-PGJ2. Comput Math Methods Med (2016) 0.75
Fabrication of a reticular poly(lactide-co-glycolide) cylindrical scaffold for the in vitro development of microvascular networks. Sci Technol Adv Mater (2017) 0.75
A pilot study on morphology and the mechanism involved in linearly patterned programmed cell necrosis in melanoma. Oncol Lett (2010) 0.75
Surface-tension driven open microfluidic platform for hanging droplet culture. Lab Chip (2016) 0.75
Multi-Material Tissue Engineering Scaffold with Hierarchical Pore Architecture. Adv Funct Mater (2016) 0.75
Investigate the Effect of Thawing Process on the Self-Assembly of Silk Protein for Tissue Applications. Biomed Res Int (2017) 0.75
Progressive Muscle Cell Delivery as a Solution for Volumetric Muscle Defect Repair. Sci Rep (2016) 0.75
Inspiration from heart development: Biomimetic development of functional human cardiac organoids. Biomaterials (2017) 0.75
Fighting Cancer with Mathematics and Viruses. Viruses (2017) 0.75
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer (1955) 10.49
Tumor dormancy in vivo by prevention of neovascularization. J Exp Med (1972) 4.34
Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst (1971) 2.83
Production and characterization of multiple-layered populations of animal cells. J Cell Biol (1965) 2.02
The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). Biochem Pharmacol (1968) 1.73
Contact and short-range interactions affecting growth of animal cells in culture. Curr Top Dev Biol (1967) 1.20
Some observations on the three-dimensional growth of L5178Y cell colonies in soft agar culture. Exp Cell Res (1971) 1.05
Mechanism of size limitation of bacterial colonies. J Infect Dis (1972) 1.01
Radiosensitivities of murine lymphoma L5178Y cells in a multi-cellular colony system. J Radiat Res (1972) 0.99
Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum (1986) 29.12
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Angiogenic factors. Science (1987) 15.22
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Role of cell shape in growth control. Nature (1978) 12.46
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (1997) 7.66
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med (1995) 7.37
Atlas of individual radiographic features in osteoarthritis. Osteoarthritis Cartilage (1995) 7.18
Isolation of a tumor factor responsible for angiogenesis. J Exp Med (1971) 7.12
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol (1993) 6.55
Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A (1994) 6.48
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res (2000) 6.42
Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95
Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol (1994) 5.76
Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A (1979) 5.70
Tumor angiogenesis. Adv Cancer Res (1985) 5.66
Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res (1977) 5.19
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (1990) 5.15
Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (1999) 4.91
Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (1989) 4.85
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83
Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76
Angiogenesis in vitro. Nature (1980) 4.46
Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg (1972) 4.37
Tumor dormancy in vivo by prevention of neovascularization. J Exp Med (1972) 4.34
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (1984) 4.27
Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst (1974) 4.05
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76
Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med (1996) 3.64
Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst (1995) 3.53
Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation (1999) 3.53
A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci (1996) 3.49
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage (1996) 3.26
Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol (1976) 3.21
Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg (1966) 3.00
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95
Harnessing optical forces in integrated photonic circuits. Nature (2008) 2.90
Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis (2004) 2.89
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88
How does extracellular matrix control capillary morphogenesis? Cell (1989) 2.84
Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A (2001) 2.81
Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest (1993) 2.71
How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res (1986) 2.69
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res (1999) 2.58
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun (1993) 2.56
Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell (1991) 2.52
Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst (1972) 2.52
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst (1994) 2.50
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry (1989) 2.49
Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood (1999) 2.49
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
A simple procedure for the long-term cultivation of chicken embryos. Dev Biol (1974) 2.46
Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med (2000) 2.46
Tumor angiogenesis. Adv Cancer Res (1974) 2.38
Protamine is an inhibitor of angiogenesis. Nature (1982) 2.30
Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med (1980) 2.27
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell (1998) 2.17
Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium. Nature (1969) 2.16
Fine structure of vascular endothelium in culture. J Ultrastruct Res (1975) 2.15
Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics (1999) 2.12
Betacellulin: a mitogen from pancreatic beta cell tumors. Science (1993) 2.10
Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst (2001) 2.10
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci U S A (1996) 2.07
Involvement of platelets in tumour angiogenesis? Lancet (1998) 2.03
The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage (2006) 2.01
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol (1997) 1.98
Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. J Natl Cancer Inst (1973) 1.95
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr (1998) 1.95
Isolation and characterization of endothelial progenitor cells from mouse embryos. Development (1998) 1.94
Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol (1987) 1.93
Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92
Acupuncture for osteoarthritis of the knee: a systematic review. Arthritis Rheum (2001) 1.91
Proceedings: Tumor angiogenesis factor. Cancer Res (1974) 1.86
Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med (1991) 1.79
Influence of geometry on control of cell growth. Biochim Biophys Acta (1975) 1.79
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem (1999) 1.78
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med (1995) 1.78
Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Biochem (1985) 1.77
Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am J Pathol (1975) 1.77
The hemostatic system as a regulator of angiogenesis. J Biol Chem (2000) 1.76
Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med (1975) 1.74
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol (1994) 1.73
Tumor angiogenesis. Rapid induction of endothelial mitoses demonstrated by autoradiography. J Cell Biol (1972) 1.72